ArticleHistopathology2025
Two similar but distinct types of breast acinar cell carcinoma: evidence from histological, immunohistochemical and molecular features.
Article in Histopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsBreast acinar cell carcinoma (AciCC) is a rare breast cancer subtype that exhibits morphological similarities to salivary gland AciCC. However, the molecular profile of breast AciCC differs significantly from that of salivary gland AciCC, suggesting that they may not be related. Whether breast AciCC represents a distinct breast cancer subtype remains controversial. METHODS AND
resultsThis study analysed two groups of breast AciCCs. Using comprehensive morphological, immunohistochemical, fluorescence in situ hybridisation and next-generation sequencing analyses, we elucidated the similarities and differences between these two distinct types of 'breast AciCCs' and their salivary gland counterpart. The first, based on morphological and immunohistochemical features, satisfied the 2019 World Health Organization diagnostic criteria for breast AciCC. Notably, NR4A3, a specific marker for salivary gland AciCC, was not expressed in these cases. We propose designating this tumour type as 'carcinoma with acinar cell differentiation'. In contrast, the second group included a case of AciCC in situ, which demonstrated morphological, immunohistochemical and molecular features identical to those of salivary gland AciCC, including NR4A3 protein overexpression and NR4A3 gene rearrangement. This case was considered a precursor of true salivary gland-type AciCC originating in the breast.
conclusionsThis study provides new insights into breast AciCC nomenclature: the widely recognised AciCC name, 'carcinoma with acinar cell differentiation' might be more appropriate. Although true salivary gland-type AciCC requires additional cases for confirmation, our case has clarified that true salivary gland-type AciCC can indeed exist in the breast.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.